愛德斯 ADUS 深 滬
等待開盤 08-08 09:30:00 美东时间
109.10
-5.840
-5.08%
華盛通- 最 高116.9038
- 今 開115.96
- 成交量 50.11万股
- 最 低 102.68
- 昨 收 114.94
- 總市值 20.07亿
- 52周最高 136.72
- 市盈率 靜 25.76
- 換手率 2.72%
- 52周最低 88.96
- 委 比 89.39%
- 總股本 1839.91万
- 歷史最高 136.72
- 量 比 1.87
- 振 幅 12.37%
- 歷史最低 3.00
- 每 手 1
- 風險率 12.44%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Addus Homecare Appoints New President and COO
Addus Homecare ( ($ADUS) ) just unveiled an announcement. On August 4, 2025, Ad...
今天 04:41
美股大行评级 | Rivian遭多家大行下调目标价；巴克莱上调超微公司目标价从130美元升至200美元
今日重点评级关注：韦德布什：维持Gossamer Bio"跑赢大市"评级，目标价从4美元升至5美元；HC Wainwright & Co.：维持EyePoint Pharmaceuticals"买入"评级，目标价从22美元升至23美元
08-07 09:46
TD Cowen Maintains Buy on Addus HomeCare, Raises Price Target to $139
TD Cowen analyst Ryan Langston maintains Addus HomeCare (NASDAQ:ADUS) with a Buy and raises the price target from $135 to $139.
08-07 02:33
Earnings Scheduled For August 4, 2025
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is likely to rep...
08-04 16:32
Adams Diversified Equity Fund Declares Distribution
Adams Diversified Equity Fund, Inc. (NYSE: ADX) announced a distribution of $0.46 per share, payable on August 28, 2025, to shareholders of record on July 28, 2025. Shareholders can elect to receive the distribution in additional shares of common stock (default) or in cash, with a deadline of August 15, 2025. The distribution sources include $0.04 from net investment income, $0.27 from net realized long-term gains, and $0.15 from return of capita...
07-18 13:00
Assessing Addus HomeCare: Insights From 5 Financial Analysts
Ratings for Addus HomeCare (NASDAQ:ADUS) were provided by 5 analysts in the pas...
07-17 05:05
Home Health Braces For Potential $1 Billion Cut In Medicare Payments
The Centers for Medicare & Medicaid Services (CMS) released a proposed rule on Monday outlining changes to how Medicare pays home health agencies (HHAs) in calendar year (CY) 2026. These updates are required by law and occur annually.
07-01 20:23
美股大行评级 | 潜在涨幅378.93%！aTyr Pharma获富国银行升目标价至25美元，维持"超配"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1143101010774646784.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 富国银行：维持aTyr Pharma(ATYR)"超配"评级，目标价从17美元升至25美元</p> <p>• 摩根大通：维持Array Technologies(ARRY)"超配"评级，目标价从12美元升至13美元</p>
06-21 08:35
JMP Securities Reiterates Market Outperform on Addus HomeCare, Maintains $150 Price Target
JMP Securities analyst Constantine Davides reiterates Addus HomeCare (NASDAQ:ADUS) with a Market Outperform and maintains $150 price target.
06-20 21:31
美股大行评级 | 潜在涨幅434.95%！VNRX获Jones Trading首予"买入"评级，目标价3美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1139478829918380033.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Guggenheim：维持Metsera(MTSR)"买入"评级，目标价从56美元升至62美元</p> <p>• 摩根大通：维持Avidity Biosciences(RNA)"超配"评级，目标价从57美元升至59美元</
06-11 09:43
